Medifast Inc [MED] stock prices are up 1.12% to $16.21 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The MED shares have gain 7.42% over the last week, with a monthly amount glided 6.02%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Medifast Inc [NYSE: MED] stock has seen the most recent analyst activity on November 05, 2024, when DA Davidson upgraded its rating to a Neutral and also boosted its price target to $17 from $16.50. Previously, DA Davidson downgraded its rating to Underperform on June 05, 2024, and dropped its price target to $17.50. On October 13, 2023, Stephens initiated with a Equal-Weight rating and assigned a price target of $82 on the stock. DA Davidson downgraded its rating to a Neutral and decreased its price target to $106 on November 04, 2022. Jefferies downgraded its rating to a Hold and reduced its price target to $150 on August 04, 2022. Jefferies upgraded its rating to Buy for this stock on January 25, 2021, and upped its price target to $265. In a note dated November 05, 2020, DA Davidson upgraded an Buy rating on this stock and boosted its target price from $180 to $205.
The stock price of Medifast Inc [MED] has been fluctuating between $14.76 and $53.79 over the past year. Currently, Wall Street analysts expect the stock to reach $17 within the next 12 months. Medifast Inc [NYSE: MED] shares were valued at $16.21 at the most recent close of the market. An investor can expect a potential return of 4.87% based on the average MED price forecast.
Analyzing the MED fundamentals
The Medifast Inc [NYSE:MED] reported sales of 674.48M for trailing twelve months, representing a drop of -40.58%. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.04 and Total Capital is 0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.00 points at the first support level, and at 15.79 for the second support level. However, for the 1st resistance point, the stock is sitting at 16.54, and for the 2nd resistance point, it is at 16.87.
Ratios To Look Out For
It’s worth pointing out that Medifast Inc [NYSE:MED]’s Current Ratio is 3.11. On the other hand, the Quick Ratio is 2.55, and the Cash Ratio is 1.59. Considering the valuation of this stock, the price to sales ratio is 0.26, the price to book ratio is 0.86 and price to earnings (TTM) ratio is 24.26.
Transactions by insiders
Recent insider trading involved SCHLACKMAN SCOTT, Director, that happened on Mar 08 ’24 when 4053.0 shares were sold.
